NCT07392970 2026-04-09
Motixafortide for MRD Sensitization in AML
Washington University School of Medicine
Phase 2 Not yet recruiting
Clinical Trials
7 trialsNCT07483476 2026-03-19
CIRCALL
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
NCT07443592 2026-03-02
LAL-2025
PETHEMA Foundation
Phase NA Not yet recruiting
NCT07301138 2025-12-24
BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients
Ruijin Hospital
Phase 2 Not yet recruiting
NCT07269067 2025-12-08
DUALFLOW
University Hospital, Bordeaux
Not yet recruiting
NCT07264010 2025-12-04
Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single-arm, Multicenter Clinical Study
Nanfang Hospital, Southern Medical University
Phase 2/3 Not yet recruiting
NCT06090786 2024-04-10
Kinetics and Impact on Survival of MRD in AML Patients Receiving Azacitidine and Venetoclax
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase NA Not yet recruiting